eFFECTOR Therapeutics, Inc. (EFTR) Tops Q1 EPS by 84c

eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) reported Q1 EPS of ($2.16), $0.84 better than the analyst estimate of ($3.00).

For earnings history and earnings-related data on eFFECTOR Therapeutics, Inc. (EFTR) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
• Hesai Group (HSAI) Tops Q1 EPS by 8c